Literature DB >> 3863709

Influence of human alpha-interferon on four human osteosarcoma xenografts in nude mice.

O Brosjö, H C Bauer, L A Broström, U Nilsonne, O S Nilsson, F P Reinholt, H Strander, B Tribukait.   

Abstract

Growth-inhibiting effects of human alpha-interferon (HuIFN-alpha) were investigated in four human osteosarcoma xenografts in nude mice. In addition to effects on growth, the HuIFN-alpha treatment was evaluated by histological examination and DNA flow cytometric analysis. Daily doses of 2 X 10(5) IU HuIFN-alpha completely arrested the growth of two osteosarcoma xenografts and partially inhibited one, whereas 1 X 10(6) IU/day were necessary to arrest the growth of the fourth. Growth inhibition was reversible and tumor size independent. The histological appearance, including mitotic indices, and S-phase proportions were unchanged in three xenografts. The mechanism of the HuIFN-alpha-induced growth inhibition of these three xenografts was therefore not considered to be a direct antiproliferative effect, but rather due to increased cell loss and/or increased cell cycle time. The modal DNA value of one xenograft was changed from aneuploid to diploid during HuIFN-alpha treatment. Histologically, these xenografts were partly replaced by normal appearing bone and bone marrow. The S-phase proportion was also reduced in these xenografts, implying that HuIFN-alpha can also have a direct antiproliferative effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863709

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Determination of subcutaneous tumor size in athymic (nude) mice.

Authors:  M M Tomayko; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.

Authors:  L A Broström; S Crnalic; R Löfvenberg; L Boquist; R Stenling
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Strategies and developments of immunotherapies in osteosarcoma.

Authors:  Jia Wan; Xianghong Zhang; Tang Liu; Xiangsheng Zhang
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

4.  Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients.

Authors:  Emilie P Buddingh; S Eriaty N Ruslan; Dagmar Berghuis; Hans Gelderblom; Jakob K Anninga; Pancras C W Hogendoorn; R Maarten Egeler; Marco W Schilham; Arjan C Lankester
Journal:  Cancer Immunol Immunother       Date:  2012-03-10       Impact factor: 6.968

Review 5.  Patient-derived xenograft models in musculoskeletal malignancies.

Authors:  Wan Lu; Tu Chao; Chen Ruiqi; Su Juan; Li Zhihong
Journal:  J Transl Med       Date:  2018-04-23       Impact factor: 5.531

Review 6.  Current and Emerging Targets in Immunotherapy for Osteosarcoma.

Authors:  Shinji Miwa; Toshiharu Shirai; Norio Yamamoto; Katsuhiro Hayashi; Akihiko Takeuchi; Kentaro Igarashi; Hiroyuki Tsuchiya
Journal:  J Oncol       Date:  2019-01-01       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.